Triad Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Triad Wealth Partners's LLY Position: Q1 2026 in Review
Triad Wealth Partners increased its Eli Lilly (LLY) stake by 74% in Q1 2026, buying an estimated $1.86M and bringing the position to 4,336 shares worth $3.25M. The position accounts for 0.26% of the portfolio, ranked #74.
Triad Wealth Partners first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Triad Wealth Partners held 4,336 shares of Eli Lilly worth $3.25M as of Q1 2026.
- Triad Wealth Partners bought 1,838 Eli Lilly shares in Q1 2026, an estimated $1.86M.
- Eli Lilly made up 0.26% of Triad Wealth Partners's portfolio in Q1 2026, its #74 holding.
- Triad Wealth Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Triad Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.